Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

间皮素 单克隆抗体 胰腺癌 癌症研究 卵巢癌 抗原 抗体 体内 医学 免疫系统 细胞毒性 癌症 免疫疗法 胰腺肿瘤 免疫学 癌细胞 肿瘤微环境 表位 生物 体外 细胞 单克隆 细胞培养 嵌合抗原受体 化学 肽 奥贝他汀 细胞疗法
作者
John Scholler,Ai Song,Mansi Deshmukh,Decheng Song,Khatuna Gabunia,Mei Ji,Shimin Liu,Ting-Jia Fan,Gayathri Gulendran,Carl H. June,Don L. Siegel
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:17: 1805950-1805950
标识
DOI:10.3389/fimmu.2026.1805950
摘要

Mesothelin is an attractive target for CAR T therapy on a number of cancer types; however, the efficacy of this therapy is diminished because the bulk of the cell surface-expressed mesothelin is shed through naturally occurring proteolysis leaving behind a short juxtamembrane peptide “stump”. The two problems this creates are one, the bulk of the target protein is no longer on the tumor cell and two, soluble, shed mesothelin persists in the tumor microenvironment and circulates in blood and other body fluids, where it can bind mesothelin-targeted CAR T cells and act as a decoy that reduces engagement with tumor cell–surface mesothelin. These issues have contributed at least in part to the lack of desired efficacy in human clinical trials utilizing CAR T cells that target membrane distal regions of mesothelin (i.e., the shed domain) such as those utilizing the variable domains of anti-mesothelin monoclonal antibodies SS1 and M5. In addition, there have been safety concerns regarding the targeting of mesothelin on normal tissues. Here we describe CAR T cells that utilize novel phage display-derived antibodies specific for the mesothelin stump domain, thus being unaffected by the natural process of mesothelin shedding. Mesothelin “stump-specific” CAR T cells (CAR 422) had cytotoxicity and in vivo activity that were comparable to previously studied anti-mesothelin CAR T cells. Importantly, CAR 422 T cells were effective against tumor cells that were resistant to conventional anti-mesothelin CAR T cells and showed reduced on-target/off tumor toxicity in a human mesothelin knock-in mouse model. Thus, CAR 422 holds potential as a next-generation therapy for challenging solid tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜的应助被LZR采纳,获得10
刚刚
jiashan发布了新的文献求助10
刚刚
许瑞琳完成签到,获得积分10
刚刚
刚刚
刚刚
NexusExplorer的应助被拼搏的不尤采纳,获得10
1秒前
今后的应助被yulong采纳,获得10
1秒前
大个的应助被ryy采纳,获得10
1秒前
xiaoxin发布了新的文献求助10
1秒前
CodeCraft的应助被友好的人英采纳,获得10
2秒前
Missy完成签到,获得积分10
3秒前
幽默的小松鼠完成签到,获得积分10
3秒前
3秒前
小L想睡觉完成签到,获得积分10
3秒前
3秒前
脑洞疼的应助被冷酷的安珊采纳,获得10
4秒前
请问请问完成签到,获得积分10
4秒前
脑洞疼的应助被荼蘼采纳,获得30
4秒前
ding的应助被霁月采纳,获得10
4秒前
JamesPei的应助被荼蘼采纳,获得10
4秒前
yk关闭了yk的文献求助
4秒前
英俊的铭的应助被荼蘼采纳,获得200
4秒前
852的应助被荼蘼采纳,获得10
4秒前
深情安青的应助被荼蘼采纳,获得50
5秒前
JamesPei的应助被荼蘼采纳,获得10
5秒前
踏实的流沙完成签到 ,获得积分10
5秒前
Shamy完成签到 ,获得积分10
5秒前
思源的应助被荼蘼采纳,获得10
5秒前
隐形曼青的应助被荼蘼采纳,获得10
5秒前
大模型的应助被荼蘼采纳,获得10
5秒前
完美世界的应助被荼蘼采纳,获得10
6秒前
7秒前
7秒前
华仔的应助被暴躁的可乐采纳,获得30
7秒前
7秒前
xushanqi发布了新的文献求助10
7秒前
damowang完成签到,获得积分10
8秒前
8秒前
8秒前
风吹麦浪的应助被Cecilia采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346